130 related articles for article (PubMed ID: 6832880)
1. Pellagra probably due to pyrazinamide: development during combined chemotherapy of tuberculosis.
Jørgensen J
Int J Dermatol; 1983; 22(1):44-5. PubMed ID: 6832880
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid-induced pellagra.
Bilgili SG; Karadag AS; Calka O; Altun F
Cutan Ocul Toxicol; 2011 Dec; 30(4):317-9. PubMed ID: 21517721
[TBL] [Abstract][Full Text] [Related]
3. Antituberculous therapy and acute liver function.
Ong EL
Lancet; 1995 May; 345(8958):1171. PubMed ID: 7723557
[No Abstract] [Full Text] [Related]
4. Antituberculous therapy and acute liver function.
Bourke SJ; White J; Stenton SC; Hendrick DJ
Lancet; 1995 May; 345(8958):1171-2. PubMed ID: 7786347
[No Abstract] [Full Text] [Related]
5. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
6. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
Wada M
Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of tuberculosis in the adult].
Schrappe M; Wassermann K; Kroegel C
Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
[No Abstract] [Full Text] [Related]
8. [Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load].
Morland L
Tidsskr Nor Laegeforen; 1990 Nov; 110(28):3608-11. PubMed ID: 2260057
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
11. [Liver injury under tuberculostatic treatment].
Fattinger K; Braunschweig S; Reichen J; Meier-Abt PJ; Krähenbühl S
Praxis (Bern 1994); 1997 Apr; 86(15):626-9. PubMed ID: 9213916
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].
de Souza AF; de Oliveira e Silva A; Baldi J; de Souza TN; Rizzo PM
Arq Gastroenterol; 1996; 33(4):194-200. PubMed ID: 9302332
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous reaction after pyrazinamide initiation].
Mulliez P; Mbassi Fouda FL; Roy Saint-Georges F
Med Mal Infect; 2011 Sep; 41(9):499-500. PubMed ID: 21458177
[No Abstract] [Full Text] [Related]
14. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic study of tuberculosis patients before and after tuberculostatic drug treatment.
Ekmekçi A; Sayli A
Mutat Res; 1995 Apr; 334(2):175-83. PubMed ID: 7885370
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
Teo SK
Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
Schaberg T; Lode H
Z Gesamte Inn Med; 1991 Jun; 46(8):276-9. PubMed ID: 1897286
[TBL] [Abstract][Full Text] [Related]
18. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
19. [Drug-induced pellagroid erythema. A case of pellagroid erythema caused by isoniazide].
Schmutz JL; Cuny JF; Trechot P; Weber M; Beurey J
Ann Dermatol Venereol; 1987; 114(4):569-76. PubMed ID: 2956917
[No Abstract] [Full Text] [Related]
20. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Pretet S; Grosset J; Perdrizet S
Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
